Literature DB >> 17503118

Complementary and alternative medicine and coping in neuroimmunological diseases.

A Apel1, B Greim, U K Zettl.   

Abstract

The utilisation of complementary and alternative medicine (CAM) is widespread in neuroimmunological diseases like multiple sclerosis (MS) but has been disregarded in research until lately. After describing the problems of definition in CAM, different categories will be described. Various confounding factors on CAM utilisation exist, though hardly investigated. Besides sociodemographic variables like education, income, gender and age, illness-related factors like severity of disease are discussed. Furthermore, the important role of coping and CAM utilisation has not been investigated in neuroimmunological diseases, yet. Results derived from our investigations on CAM utilisation in MS indicate that users of CAM apply coping strategies, such as "rumination", "search for information" and "search for meaning in religion", more frequently than non-users and that current CAM utilisation is related to depression. Further research is needed in this field, as well as in other neuroimmunological diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17503118     DOI: 10.1007/s00415-007-2027-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  Complementary/alternative medicine for epilepsy in Arizona.

Authors:  J I Sirven; J F Drazkowski; R S Zimmerman; J J Bortz; D L Shulman; M Macleish
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

2.  Suicide and multiple sclerosis: an epidemiological investigation.

Authors:  E N Stenager; E Stenager; N Koch-Henriksen; H Brønnum-Hansen; K Hyllested; K Jensen; U Bille-Brahe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

3.  Use of alternative/complementary therapy in breast cancer patients--a psychological perspective.

Authors:  R Moschèn; G Kemmler; H Schweigkofler; B Holzner; M Dünser; R Richter; W W Fleischhacker; B Sperner-Unterweger
Journal:  Support Care Cancer       Date:  2001-06       Impact factor: 3.603

4.  Why patients use alternative medicine: results of a national study.

Authors:  J A Astin
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

5.  Use of unconventional therapies by individuals with multiple sclerosis.

Authors:  Sangeetha Nayak; Robert J Matheis; Nancy E Schoenberger; Samuel C Shiflett
Journal:  Clin Rehabil       Date:  2003-03       Impact factor: 3.477

6.  [Use of alternative treatments by patients with myasthenia gravis].

Authors:  R Beekman; H J Oosterhuis
Journal:  Ned Tijdschr Geneeskd       Date:  1994-02-05

7.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

Authors:  D M Eisenberg; R B Davis; S L Ettner; S Appel; S Wilkey; M Van Rompay; R C Kessler
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

8.  Increased depression in multiple sclerosis patients. A meta-analysis.

Authors:  D S Schubert; R H Foliart
Journal:  Psychosomatics       Date:  1993 Mar-Apr       Impact factor: 2.386

9.  Prevalence and cost of alternative medicine in Australia.

Authors:  A H MacLennan; D H Wilson; A W Taylor
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

10.  Depression and multiple sclerosis.

Authors:  A D Sadovnick; R A Remick; J Allen; E Swartz; I M Yee; K Eisen; R Farquhar; S A Hashimoto; J Hooge; L F Kastrukoff; W Morrison; J Nelson; J Oger; D W Paty
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  6 in total

1.  Conservative care of temporomandibular joint disorder in a 35-year-old patient with spinal muscular atrophy type III: a case study.

Authors:  Sébastien Houle; Martin Descarreaux
Journal:  J Chiropr Med       Date:  2009-12

Review 2.  Complementary and alternative medicine in multiple sclerosis.

Authors:  Annett Apel-Neu; U K Zettl
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

Review 3.  Complementary and alternative therapies in multiple sclerosis: a systematic literature classification and analysis.

Authors:  Goli Arji; Hossein Rezaeizadeh; Abdolrreza Naser Moghadasi; Mohammad Ali Sahraian; Mehrdad Karimi; Mojtaba Alizadeh
Journal:  Acta Neurol Belg       Date:  2022-01-21       Impact factor: 2.396

4.  Understanding unexpected courses of multiple sclerosis among patients using complementary and alternative medicine: A travel from recipient to explorer.

Authors:  Anita Salamonsen; Laila Launsø; Tove E Kruse; Sissel H Eriksen
Journal:  Int J Qual Stud Health Well-being       Date:  2010-07-02

5.  The risk of polypharmacy, comorbidities and drug-drug interactions in women of childbearing age with multiple sclerosis.

Authors:  Niklas Frahm; Michael Hecker; Silvan Elias Langhorst; Pegah Mashhadiakbar; Marie-Celine Haker; Uwe Klaus Zettl
Journal:  Ther Adv Neurol Disord       Date:  2020-12-19       Impact factor: 6.570

6.  Navigating the "liberation procedure": a qualitative study of motivating and hesitating factors among people with multiple sclerosis.

Authors:  Michelle Ploughman; Chelsea Harris; Stephen H Hogan; Cynthia Murray; Michelle Murdoch; Mark W Austin; Mark Stefanelli
Journal:  Patient Prefer Adherence       Date:  2014-09-10       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.